Europe Updates COVID-19 Vaccine Safety Reports

The European Medicines Agency (EMA), which monitors the safety of COVID-19 vaccines Authorised in the European Union (EU), published updated safety notices on September 8, 2021.

The monthly safety updates give an overview of each Authorized COVID-19 vaccine's safety evaluation.

The COVID-19 vaccines Authorized for use in the EU are as follows:

• Comirnaty
• Spikevax (previously COVID-19 Vaccine Moderna)
• Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
• COVID-19 Vaccine Janssen

For more information on these reports, see the European Suspected Adverse Drug Reactions database (www.adrreports.eu).

Over 377 million doses of COVID-19 vaccines have been given to people in the EU and European Economic Area as of the end of July 2021.

Located in The Netherlands, the European Medicines Agency is a decentralized agency of the EU responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the EU. The EMA is governed by an independent Management Board.